TickerFactsScreenerDevelopers

Avalo Therapeutics, Inc. (AVTX) — Total Assets

Annual figures by fiscal year, from SEC filings.

2014: $12.32M2015: $21.66M2016: $5.77M2017: $42.81M2018: $70.25M2019: $36.11M2020: $43.76M2021: $80.21M2022: $33.37M2023: $20.99M2024: $150.73M2025: $116.46M$116.46M
2014Total Assets (USD)2025
Fiscal YearTotal AssetsChange YoY
2025$116.46M-22.7%
2024$150.73M+618.0%
2023$20.99M-37.1%
2022$33.37M-58.4%
2021$80.21M+83.3%
2020$43.76M+21.2%
2019$36.11M-48.6%
2018$70.25M+64.1%
2017$42.81M+642.0%
2016$5.77M-73.4%
2015$21.66M+75.8%
2014$12.32M—